论文部分内容阅读
目的:分析盐酸氨溴索在慢性支气管炎治疗中的应用价值。方法:将68例慢性支气管炎患者随机分为两组,对照组33例行常规治疗,观察组35例加用盐酸氨溴索治疗,比较两组治疗效果。结果:治疗期间两组不良反应发生率组间差异不显著(P>0.05),观察组治疗总有效率明显高于对照组(P<0.05),且治疗后两组患者症状积分均明显低于治疗前,且观察组明显低于对照组(P<0.05)。结论:盐酸氨溴索可有效减轻慢性支气管炎患者临床症状,提高临床疗效,且不会导致不良反应发生风险增加,值得推广。
Objective: To analyze the value of ambroxol hydrochloride in the treatment of chronic bronchitis. Methods: Sixty-eight patients with chronic bronchitis were randomly divided into two groups. The control group, 33 cases were treated routinely, and the observation group, 35 cases were treated with ambroxol hydrochloride. The therapeutic effect was compared between the two groups. Results: There was no significant difference in the incidence of adverse reactions between the two groups during the treatment (P> 0.05). The total effective rate in the observation group was significantly higher than that in the control group (P <0.05), and symptom scores were significantly lower in both groups after treatment Before treatment, and the observation group was significantly lower than the control group (P <0.05). Conclusion: Ambroxol hydrochloride can effectively alleviate the clinical symptoms of patients with chronic bronchitis, improve clinical efficacy, and will not lead to increased risk of adverse reactions, it is worth promoting.